Skip to main content

Table 1 Demographic and clinical data for study participants ( N= 27)

From: Characterization of the vaginal microbiota of healthy Canadian women through the menstrual cycle

Demographics  
Age 34.96 ± 4.17 (18-53)
BMI 23.47 ± 1.86 (16.8-36)
Ethnicity  
Asian 9 (33.3%)
Caucasian 15 (55.6%)
Other 3 (11.1%)
Substance use  
Current smoking 2 (7.4%)
Current alcohol use 20 (74.1%)
Sexual history  
Marital status  
Partnered 9 (33.3%)
Single 18 (66.7%)
Sexual partners in past year 1.04 ± 0.28 (0-3)
Sexual partners in past 2 months 0.78 ± 0.23 (0-2)
Vaginal intercourse during study period 17 (63.0%)
Condom use during study period 8 (29.6%)
Previous pregnancy 10 (37.0%)
Surgical sterilization 4 (14.8%)
Menstrual cycle  
Cycle duration (days) 28.05 ± 0.68 (26-31)
Tampon use during study period 12 (44.4%)
BV and STI history  
Diagnosed with BV, yeast, or STI in lifetime 22 (81.5%)
Diagnosed with BV in lifetime 2 (7.4%)
BV episode in past year 1 (3.7%)
Antimicrobial use in past 2 months a  
Oral 1 (3.7%)
Topical 2 (7.4%)
  1. aNo intravaginal antibiotics.
  2. BMI, body mass index; BV, bacterial vaginosis;
  3. STI, sexually transmitted infection.
  4. Continuous variables are reported as means ± 95% CI (range).
  5. Categoric variables are reported as N (%).